STOCK TITAN

Schedule 13G: Hilve Holdings and M. Stiskin Report 5.7% of ECOR

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Hilve Holdings Limited and Mikhail Stiskin disclosed beneficial ownership of 432,000 shares of electroCore, Inc. common stock, representing 5.7% of the outstanding shares based on 7,583,445 shares outstanding as of August 5, 2025. Hilve Holdings, a Cyprus company, holds the shares directly and has sole voting and dispositive power over them. Mr. Stiskin, an Israeli citizen and sole shareholder of Hilve Holdings, may be deemed the beneficial owner with identical sole voting and dispositive power. The filing states the stake was not acquired to change or influence control of the issuer.

Positive

  • Clear disclosure of a >5% beneficial ownership (432,000 shares, 5.7% of outstanding shares based on 7,583,445 shares).
  • Reporting persons hold sole voting and dispositive power over the reported shares, providing transparency about control of the stake.
  • Filed on Schedule 13G with certification of non-control intent, indicating the holders state the position is passive rather than an attempt to influence control.

Negative

  • None.

Insights

TL;DR: A disclosed 5.7% stake with sole voting and dispositive power; filing asserts no intent to influence control.

The Schedule 13G reports a passive, greater-than-5%-owner disclosure by Hilve Holdings Ltd and beneficial attribution to Mikhail Stiskin. The filing provides clear ownership metrics: 432,000 shares, 5.7% of a 7,583,445-share base, and sole voting/dispositive power. Because the report is on Schedule 13G and includes a certification of non-control purpose, this is treated as a passive disclosure rather than an active proxy or control attempt. Materiality is limited to ownership concentration and transparency.

TL;DR: Ownership concentrated in a single Cyprus-held vehicle with beneficial attribution to its sole shareholder; governance implications are limited.

The document identifies governance-relevant facts: Hilve Holdings holds the shares directly with sole authority to vote and dispose, and Mr. Stiskin is the sole shareholder of that holding company. The filing’s certification that the stake is not intended to change control reduces immediate regulatory or takeover signalling. For board-level influence, 5.7% is notable but not controlling; further disclosures would be required if intentions change.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Hilve Holdings Ltd
Signature:/s/ Asya Andreeva
Name/Title:Director
Date:09/08/2025
Mikhail Stiskin
Signature:/s/ Mikhail Stiskin
Name/Title:self
Date:09/08/2025

FAQ

How many shares of ECOR does Hilve Holdings Ltd report owning?

The filing reports 432,000 shares of electroCore, Inc. common stock.

What percentage of ECOR does the reported stake represent?

The reported stake represents 5.7% of the outstanding common stock, based on 7,583,445 shares outstanding as of August 5, 2025.

Who may be deemed the beneficial owner of the shares?

Hilve Holdings Ltd directly holds the shares; Mikhail Stiskin, as sole shareholder of Hilve Holdings, may be deemed the beneficial owner.

Do the reporting persons claim intent to change control of ECOR?

No. The filing includes a certification that the securities were not acquired to change or influence control of the issuer.

Where is Hilve Holdings Ltd organized and where is Mr. Stiskin a citizen?

Hilve Holdings Ltd is organized in the Republic of Cyprus; Mikhail Stiskin is a citizen of Israel.
Electrocore

NASDAQ:ECOR

ECOR Rankings

ECOR Latest News

ECOR Latest SEC Filings

ECOR Stock Data

35.34M
5.14M
37.28%
15.51%
5.96%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
ROCKAWAY